Abcellera Biologics shares owned by Credit Suisse
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Abcellera Biologics by Credit Suisse
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $26M | 4.6M | 5.71 |
2023-09-30 | $21M | 4.6M | 4.60 |
2023-06-30 | $30M | 4.6M | 6.46 |
2023-03-31 | $35M | 4.6M | 7.54 |
2022-12-31 | $42M | 4.1M | 10.13 |
2022-09-30 | $41M | 4.1M | 9.90 |
2022-06-30 | $28M | 2.6M | 10.64 |
2022-03-31 | $26M | 2.7M | 9.76 |
2021-12-31 | $38M | 2.6M | 14.30 |
2021-09-30 | $56M | 2.8M | 20.05 |
2021-06-30 | $58M | 2.6M | 22.00 |
2021-03-31 | $76M | 2.3M | 33.33 |